Download PDFPDF
CP-067 Effectiveness and safety of rituximab in autoimmune kidney disease after 12 months of follow-up
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address